Search Results - "Antman, Karen"

Developing Core Competencies for the Prevention and Management of Prescription Drug Misuse: A Medical Education Collaboration in Massachusetts by Antman, Karen H, Berman, Harris A, Flotte, Terence R, Flier, Jeffrey, Dimitri, Dennis M, Bharel, Monica

“…Drug overdose has become the leading cause of injury death in the United States. More than half of those deaths involve prescription drugs, specifically…”
Get full text

Imatinib Mesylate — A New Oral Targeted Therapy by Savage, David G, Antman, Karen H

“…This review discusses the development and uses of imatinib mesylate, a protein tyrosine kinase inhibitor useful in the treatment of chronic myelogenous…”
Get full text

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs by Tefferi, Ayalew, MD, Kantarjian, Hagop, MD, Rajkumar, S. Vincent, MD, Baker, Lawrence H., DO, Adamson, John W., MD, Advani, Ranjana Hira, MD, Allison, James, MD, Antman, Karen H., MD, Bast, Robert C., MD, Bennett, John M., MD, Benz, Edward J., MD, Berliner, Nancy, MD, Bhatia, Ravi, MD, Bhatia, Smita, MD, Bhojwani, Deepa, MD, Blanke, Charles D., MD, Bloomfield, Clara D., MD, Bosserman, Linda, MD, Byrd, John C., MD, Cabanillas, Fernando, MD, Canellos, George Peter, MD, Chabner, Bruce A., MD, Chanan-Khan, Asher, MD, Cheson, Bruce, MD, Cohn, Susan L., MD, Colon-Otero, Gerardo, MD, Cortes, Jorge, MD, Coutre, Steven, MD, Cristofanilli, Massimo, MD, Curran, Walter J., MD, Daley, George Q., MD, PhD, DeAngelo, Daniel J., MD, PhD, Deeg, H. Joachim, MD, Einhorn, Lawrence H., MD, Erba, Harry P., MD, PhD, Esteva, Francisco J., MD, PhD, Estey, Elihu, MD, Fidler, Isaiah J., DVM, PhD, Foran, James, MD, Forman, Stephen, MD, Freireich, Emil, MD, Fuchs, Charles, MD, MPH, George, James N., MD, Gertz, Morie A., MD, Golomb, Harvey, MD, Greenberg, Peter, MD, Gutterman, Jordan, MD, Handin, Robert I., MD, Hoff, Paulo Marcelo, MD, Hoffman, Ronald, MD, Horowitz, Mary, MD, MS, Hortobagyi, Gabriel N., MD, Hudis, Clifford, MD, Issa, Jean Pierre, MD, Kantoff, Philip W., MD, Kaushansky, Kenneth, MD, Khayat, David, MD, PhD, Kipps, Thomas J., MD, PhD, Kripke, Margaret, PhD, Kyle, Robert A., MD, Larson, Richard A., MD, Lawrence, Theodore S., MD, PhD, Link, Michael P., MD, Lippman, Scott M., MD, Lonial, Sagar, MD, Lyman, Gary H., MD, MPH, Markman, Maurie, MD, Messinger, Yoav, MD, Mulvey, Therese M., MD, Perez-Soler, Roman, MD, Pollock, Raphael, MD, PhD, Prchal, Josef, MD, Press, Oliver, MD, PhD, Radich, Jerald, MD, Rai, Kanti, MD, Rosenberg, Saul A., MD, Rugo, Hope, MD, Runowicz, Carolyn D., MD, Sandmaier, Brenda M., MD, Saven, Alan, MD, Schafer, Andrew I., MD, Schiffer, Charles, MD, Sekeres, Mikkael A., MD, MS, Silver, Richard T., MD, Siu, Lillian L., MD, Steensma, David P., MD, Stewart, F. Marc, MD, Stock, Wendy, MD, MA, Stone, Richard, MD, Storb, Rainer, MD, Strong, Louise C., MD, Tallman, Martin S., MD, Thompson, Michael, MD, PhD, Ueno, Naoto T., MD, PhD, Van Etten, Richard A., MD, PhD, Vose, Julie M., MD, MBA, Wiernik, Peter H., MD, Younes, Anas, MD, Zelenetz, Andrew D., MD, PhD, LeMaistre, Charles A., MD

Get full text

Introduction: The History of Arsenic Trioxide in Cancer Therapy by Antman, Karen H.

“…Although arsenic can be poisonous, and chronic arsenic exposure from industrial or natural sources can cause serious toxicity, arsenic has been used…”
Get full text

Pancreatic Proteolytic Enzyme Therapy Compared With Gemcitabine-Based Chemotherapy for the Treatment of Pancreatic Cancer by Chabot, John A, Tsai, Wei-Yann, Fine, Robert L, Chen, Chunxia, Kumah, Carolyn K, Antman, Karen A, Grann, Victor R

“…PURPOSE Conventional medicine has had little to offer patients with inoperable pancreatic adenocarcinoma; thus, many patients seek alternative treatments. The…”
Get full text

Reduction of Paclitaxel-induced Peripheral Neuropathy with Glutamine by VAHDAT, Linda, PAPADOPOULOS, Kyriakos, GARRETT, Thomas, SAVAGE, David, ANTMAN, Karen, HESDORFFER, Charles S, BALMACEDA, Casilda, LANGE, Dale, LEUIN, Shelby, KAUFMAN, Elizabeth, DONOVAN, Diana, FREDERICK, Deborah, BAGIELLA, Emilia, TIERSTEN, Amy, NICHOLS, Gwen

“…Purpose: Dose-limiting toxicity of many newer chemotherapeutic agents is peripheral neuropathy. Prior attempts to reduce this side effect have been…”
Get full text

The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma by Renshaw, A A, Dean, B R, Antman, K H, Sugarbaker, D J, Cibas, E S

“…Treatment of malignant mesothelioma (MM) at an early stage results in increased survival. Cytologic examination of pleural effusions is one of the first…”
Get more information

Building on #MeToo to Enhance the Learning Environment for US Medical Schools by Antman, Karen

“…Antman discusses the role of the #MeToo format in enhancing the learning environment among the medical schools in the U.S. The author mentions that surveys of…”
Get full text

Update on malignant mesothelioma by Antman, Karen, Hassan, Raffit, Eisner, Milton, Ries, Lynn A G, Edwards, Brenda K

“…Mesotheliomas are uncommon in the United States, with an incidence of about 3,000 new cases per year (or a risk of about 11 per million Americans per year)…”
Get more information

High-Dose Versus Standard Chemotherapy in Metastatic Breast Cancer: Comparison of Cancer and Leukemia Group B Trials With Data From the Autologous Blood and Marrow Transplant Registry by Berry, D. A.

Get full text

Randomized trials of high dose chemotherapy for breast cancer by Antman, Karen H

“…‘Now is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning’ Winston Churchill in a speech to the Canadian…”
Get full text

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression by Antman, K S, Griffin, J D, Elias, A, Socinski, M A, Ryan, L, Cannistra, S A, Oette, D, Whitley, M, Frei, 3rd, E, Schnipper, L E

“…An increase in the dose of chemotherapy enhances the response of many experimental and clinical cancers, but the extent of dose escalation is often limited by…”
Get more information

Ice Bound: A Doctor's Incredible Battle for Survival at the South Pole by Antman, Dr. Karen

Get full text

Kaposi's Sarcoma by Antman, Karen, Chang, Yuan

“…In 1872, Moritz Kaposi, a Hungarian dermatologist, described five men with aggressive “idiopathic multiple pigmented sarcomas of the skin.” 1 One patient died…”
Get full text

Drug therapy: Imatinib mesylate: A new oral targeted therapy by SAVAGE, David G, ANTMAN, Karen H

Get full text

High-dose ifosfamide with mesna and granuloctye-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma: A Southwest Oncology Group Study by TALBOT, Susan M, RANKIN, Cathryn, TAUB, Robert N, BALCERZAK, Stanley P, BHOOPALAM, Nirmala, CHAPMAN, Robert A, BAKER, Laurence H, MIDDLEMAN, Edward L, ANTMAN, Karen H

Get full text

Protocol for the Examination of Specimens From Patients With Tumors of the Peritoneum by Scully, Robert E, Antman, Karen H

Get full text

Adjuvant therapy of osteosarcoma—A Phase II trial by Zalupski, Mark M., Rankin, Cathryn, Ryan, James R., Lucas, David R., Muler, Jeffrey, Lanier, Keith S., Budd, George Thomas, Biermann, J. Sybil, Meyers, Frederick J., Antman, Karen

“…BACKGROUND The objective of this study was to estimate the time to treatment failure and survival rate of the three‐drug combination of doxorubicin, cisplatin,…”
Get full text

High-Dose Chemotherapy for Breast Cancer by Antman, Karen H, Heitjan, Daniel F, Hortobagyi, Gabriel N

“…Antman et al report of the results of nine randomized clinical trials involving the use of high-dose chemotherapy in the treatment of metastatic breast cancer…”
Get full text

Natural history and epidemiology of malignant mesothelioma by Antman, K H

“…Asbestos exposure constitutes the primary cause of pleural and peritoneal mesothelioma in humans. Risk relates to the duration and intensity of exposure. Thus,…”
Get more information